Paclitaxel improves thrombopoiesis in the absence of thrombopoietin receptor (Mpl)
- 20 September 2024
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 22 (12) , 3599-3613
Abstract
No abstract availableKeywords
Funding Information
- Key Technologies Research and Development Program (2023YFA1800100, 2018YFA0800200)
- Guangdong Provincial Natural Science Foundation (2024B1515040019)
- National Natural Science Foundation of China (32370874, 32270875)
- National Key Research and Development Program of China
- Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme
This publication has 69 references indexed in Scilit:
- Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of DesensitizationClinical Reviews in Allergy & Immunology, 2023
- Using Zebrafish (Danio rerio) to Assess Gene Function in Thrombus Formation2011
- The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthaseArchives of Pharmacal Research, 2010
- Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicityCancer Immunology, Immunotherapy, 2010
- Regulation of megakaryocytic differentiation of K562 cells by FosB, a member of the Fos family of AP-1 transcription factorsCellular and Molecular Life Sciences, 2009
- Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat modelCancer Chemotherapy and Pharmacology, 2002
- Hematopoietic Deficiencies in c‐mpl and TPO Knockout MiceStem Cells, 1998
- Expression of ZebrafishragGenes during Early Development Identifies the ThymusDevelopmental Biology, 1997
- Paclitaxel (Taxol)Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1994
- The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.The EMBO Journal, 1989